Head-to-head · Cost-Efficiency Index
Navio MD vs BiltRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Navio MD
Shoppers who want compounded tirzepatide with a brand-name fallback path on the same platform, 48 states.
Visit Navio MDBiltRx
Cost-first shoppers who want low-cost compounded glp-1 from a legitscript-verified provider.
Visit BiltRxThe verdict
Navio MD takes it, leading the Cost-Efficiency Index 73 to 72. NavioMD is a 48-state telehealth platform selling compounded tirzepatide from $189/mo plus brand-name Ozempic, Zepbound, and Mounjaro at near-retail 'as low as' prices. BiltRx still earns a C — Cost-first shoppers who want low-cost compounded glp-1 from a legitscript-verified provider.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Navio MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Navio MD | BiltRx |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 72/100 |
| Semaglutide / mo | $345/mo (brand Ozempic) | $125/mo (all doses, compounded) |
| Tirzepatide / mo | $189/mo (starting dose, compounded) | $129/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $4,140 | $1,500 |
| Tirzepatide / yr (modeled) | $2,268 | $1,548 |
| Coverage | 48 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Yes |
| Rank here | #69 | #73 |
Navio MD
73/100Where the value is
- LegitScript certified with board-certified providers claimed
- Both compounded and brand-name options on one platform
- 48-state coverage with the two exclusions (AL, MS) explicitly disclosed rather than hidden
The tradeoffs
- No compounded semaglutide offered — only brand-name Ozempic for that molecule, at a much higher price than compounded competitors
- All prices are 'as low as' floors; the exact dose tied to each starting price is not published
BiltRx
72/100Where the value is
- Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
- LegitScript verified and HIPAA compliant
- Names its 503A compounding pharmacies (Boothwyn and Southend)
The tradeoffs
- Covered states are behind a check-availability gate, not listed
- Starting prices may rise depending on plan and dose
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.